Carmustine implants and temozolomide for the treatment of newly diagnosed high grade glioma
Health Quality Improvement Scotland
Record ID 32007000739
English
Details
Project Status:
Completed
URL for project:
http://nhshealthquality.org
Year Published:
2007
URL for published report:
n/a
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Scotland
MeSH Terms
- Age Factors
- Aged
- Chemotherapy, Adjuvant
- Combined Modality Therapy
- Cost-Benefit Analysis
- Disease-Free Survival
- Drug Implants
- Female
- Male
- Middle Aged
- Models, Econometric
- Neoplasm Staging
- Quality of Life
- Antineoplastic Agents, Alkylating
- Antineoplastic Combined Chemotherapy Protocols
- Brain Neoplasms
- Dacarbazine
- Glioma
- Carmustine
- Temozolomide
Contact
Organisation Name:
Quality Improvement Scotland
Contact Address:
Delta House, 50 West Nile Street Glasgow G1 2NP Scotland United Kingdom Tel: +44 141 225 6988; Fax: +44 141 221 3262
Contact Name:
shtg.hcis@nhs.net
Contact Email:
shtg.hcis@nhs.net
Copyright:
<p>NHS Quality Improvement Scotland (NHS QIS)</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.